CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-10 | HIGGINS JOHN L Chief Executive Officer | Option exercise | +29,790 | $16.14 | $481K | 119,209 |
| 2019-01-10 | HIGGINS JOHN L Chief Executive Officer | Option exercise · Incentive Stock Option (right to buy) | −29,790 | 0 | ||
| 2019-01-10 | HIGGINS JOHN L Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −4,000 | 0 | ||
| 2018-12-17 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +3,400 | $21.92 | $75K | 37,063 |
| 2018-12-17 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise · Employee Stock Option (right to buy) | −3,400 | 244 | ||
| 2018-12-12 | FOEHR MATTHEW W President and COO | Option exercise | +7,999 | $9.97 | $80K | 113,387 |
| 2018-12-12 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −7,999 | 29,895 | ||
| 2018-10-24 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +2,688 | $14.47 | $39K | 32,451 |
| 2018-10-24 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +1,212 | $21.92 | $27K | 33,663 |
| 2018-10-24 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise · Employee Stock Option (right to buy) | −1,212 | 3,644 | ||
| 2018-10-24 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise · Incentive Stock Option (right to buy) | −2,688 | 0 | ||
| 2018-10-12 | Davis Todd C Director | Option exercise | +2,754 | $89.75 | $247K | 45,310 |
| 2018-10-12 | Davis Todd C Director | Option exercise | +2,329 | $119.30 | $278K | 47,639 |
| 2018-10-12 | Davis Todd C Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,754 | 0 | ||
| 2018-10-12 | Davis Todd C Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,329 | 0 | ||
| 2018-10-11 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +2,000 | $14.47 | $29K | 29,763 |
| 2018-10-11 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise · Incentive Stock Option (right to buy) | −2,000 | 2,688 | ||
| 2018-10-08 | Davis Todd C Director | Sale | −2,500 | $253.99 | $635K | 42,556 |
| 2018-10-01 | KOZARICH JOHN W Director | Sale | −2,500 | $275.04 | $688K | 26,142 |
| 2018-10-01 | FOEHR MATTHEW W President and COO | Option exercise | +2,088 | $9.97 | $21K | 105,388 |
Page 47 of 55 · 1,097 trades